Stergiou, I.E.; Palamaris, K.; Levidou, G.; Tzimou, M.; Papadakos, S.P.; Mandrakis, G.; Masaoutis, C.; Rontogianni, D.; Theocharis, S.
PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression. Biomedicines 2024, 12, 772.
https://doi.org/10.3390/biomedicines12040772
AMA Style
Stergiou IE, Palamaris K, Levidou G, Tzimou M, Papadakos SP, Mandrakis G, Masaoutis C, Rontogianni D, Theocharis S.
PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression. Biomedicines. 2024; 12(4):772.
https://doi.org/10.3390/biomedicines12040772
Chicago/Turabian Style
Stergiou, Ioanna E., Kostas Palamaris, Georgia Levidou, Maria Tzimou, Stavros P. Papadakos, Georgios Mandrakis, Christos Masaoutis, Dimitra Rontogianni, and Stamatios Theocharis.
2024. "PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression" Biomedicines 12, no. 4: 772.
https://doi.org/10.3390/biomedicines12040772
APA Style
Stergiou, I. E., Palamaris, K., Levidou, G., Tzimou, M., Papadakos, S. P., Mandrakis, G., Masaoutis, C., Rontogianni, D., & Theocharis, S.
(2024). PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression. Biomedicines, 12(4), 772.
https://doi.org/10.3390/biomedicines12040772
